CSC Beyond, Cognitive Technology Department, in association with Qatar Foundation; Dr. Fouad Alshaban, MD, MSC, PhD.
Lead of the Autism Epidemiology Research Team, Neurological Disorders Research Center, Qatar Biomedical Research
Institute, Hamad Bin Khalifa University, Doha, Qatar
A Cognitive/Semantical Resource Research on the publication of: “A recommendation for the use of chloroquine,
hydroxychloroquine, primaquine, or tafenoquine for prophylaxis against the 2019 novel coronavirus (COVID-19) with note to
the ophthalmic considerations”.